Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women

ClinicalTrials.gov ID: NCT00318500

Public ClinicalTrials.gov record NCT00318500. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 1:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of 75 mg and 150 mg Doses of ERB-041 on the Reduction of Symptoms Associated With Endometriosis During Treatment and Post Treatment in Reproductive-Aged Women

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the efficacy and safety of two doses of ERB-041 (75 mg and 150 mg) relative to placebo on the relief of endometriosis-related symptoms (dysmenorrhea, pelvic pain, and deep dyspareunia) in reproductive aged women.

Study identification

NCT ID
NCT00318500
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
150 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2006
Primary completion
Not listed
Completion
Nov 30, 2006
Last update posted
Dec 9, 2007

2006

United States locations

U.S. sites
49
U.S. states
24
U.S. cities
44
Facility City State ZIP Site status
Not listed Montgomery Alabama 36116
Not listed Chandler Arizona 85225
Not listed Phoenix Arizona 85032
Not listed Phoenix Arizona 85035
Not listed Tucson Arizona 85712
Not listed San Francisco California 94115
Not listed Vista California 92083
Not listed Denver Colorado 80202
Not listed Denver Colorado 80206
Not listed New Britain Connecticut 06050
Not listed Clearwater Florida 33759
Not listed New Port Richey Florida 34652
Not listed Plantation Florida 33324
Not listed Venice Florida 34285
Not listed West Palm Beach Florida 33401
Not listed West Palm Beach Florida 33409
Not listed Marietta Georgia 30066
Not listed Idaho Falls Idaho 83404
Not listed Oak Brook Illinois 60523
Not listed Evansville Indiana 47714
Not listed Reno Nevada 89502
Not listed Lawrenceville New Jersey 08648
Not listed Durham North Carolina 27710
Not listed New Bern North Carolina 28562
Not listed Raleigh North Carolina 27612
Not listed Winston-Salem North Carolina 27103
Not listed Cleveland Ohio 44122
Not listed Miamisburg Ohio 45342
Not listed Oklahoma City Oklahoma 73112
Not listed Portland Oregon 97210
Not listed Abington Pennsylvania 19001
Not listed Lansdale Pennsylvania 19446
Not listed Philadelphia Pennsylvania 19107
Not listed Philadelphia Pennsylvania 19114
Not listed Pittsburgh Pennsylvania 15243
Not listed Columbia South Carolina 29201
Not listed Greenville South Carolina 29607
Not listed Bristol Tennessee 37620
Not listed Chattanooga Tennessee 37403
Not listed Memphis Tennessee 38119
Not listed Corpus Christi Texas 78414
Not listed San Antonio Texas 78229
Not listed West Valley City Utah 84120
Not listed Norfolk Virginia 23507
Not listed Richmond Virginia 23233
Not listed Richmond Virginia 23294
Not listed Virginia Beach Virginia 23456
Not listed Renton Washington 98055
Not listed Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00318500, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2007 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00318500 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →